Skip to content

Clinical trials

Phase 2 Retinal Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Degeneration Phase: Phase 2 Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20111
20151
20191
20204
20212
20222
20233
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated5
Active, not recruiting2
Enrolling by invitation2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beacon Therapeutics3
Gyroscope Therapeutics Limited3
Gemini Therapeutics, Inc.2
Nanoscope Therapeutics Inc.2
Alkahest, Inc.1
Bay Area Retina Associates1
Oxular Limited1
Seoul National University Hospital1
Tyrogenex1
Unity Biotechnology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Degeneration17
Retinal Diseases12
Eye Diseases10
Macular Degeneration8
Geographic Atrophy5
Anetoderma3
Eye Diseases, Hereditary3
Edema2
Macular Edema2
Retinal Dystrophies2

Trials

Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.